Page last updated: 2024-08-23

paclitaxel and Hypopharyngeal Cancer

paclitaxel has been researched along with Hypopharyngeal Cancer in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (3.85)	18.2507
2000's	15 (57.69)	29.6817
2010's	10 (38.46)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, X; Lv, Z; Ma, J; Xu, W	1
Ho, K; Morfin, C; Slowinska, K	1
Arai, A; Hirano, S; Kinoshita, S; Konishi, E; Mitsuda, J; Mori, D; Ozawa, S; Saburi, S; Takenaka, M; Tsujikawa, T; Yoshimura, K	1
Chen, D; Shi, RJ; Sun, YY; Wang, PH; Wang, T; Wu, QW; Xu, CZ	1
Li, J; Lv, Z; Ma, J; Mu, Y; Tian, J; Wang, H; Xu, W; Yu, L; Zou, J	1
Li, X; Lu, X; Zhang, M	1
Budach, W; Dietz, A; Dreyhaupt, J; Eckel, H; Engenhardt-Cabillic, R; Flentje, M; Hagen, R; Hess, M; Hoppe, F; Jens, B; Kuhnt, T; Niewald, M; Pfreundner, L; Plinkert, P; Pritsch, M; Rudat, V; Schneider, P; Schröder, M; Schröder, U; Vanselow, B; Werner, JA; Zenner, HP	1
Hagen, R; Hoppe, F; Pfreundner, L; Relic, A; Scheich, M; Stapf, J; Voelter, C	1
Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F	1
Cullen, KJ; Goloubeva, O; Kwok, Y; Ord, R; Parekh, A; Strome, S; Suntharalingam, M; Taylor, R; Wolf, J; Zimrin, A	1
Li, J; Lu, S; Ma, J; Tian, J; Wang, H; Xu, W; Yu, L	1
Guntinas-Lichius, O; Klubmann, JP; Müller, RP; Preuss, SF; Semrau, R; Temming, S	1
Kawabori, S; Taniguchi, M; Watanabe, A	1
Barros, AP; Carrara-de Angelis, E; Feher, O; Kowalski, LP; Nishimoto, IN	1
Miyahara, H; Naito, K; Yane, K	1
Bratengeier, K; Flentje, M; Hagen, R; Helms, J; Hoppe, F; Pfreundner, L; Preisler, V; Willner, J	1
Becker, A; Bloching, M; Dunst, J; Hänsgen, G; Kuhnt, T; Lotterer, E; Passmann, M; Pelz, T; Pigorsch, S	1
Egli, F; Jost, L; Moosmann, P; Stahel, RA	1
Carvalho, AL; Feher, O; Gomez, MV; Kowalski, LP; Liberman, PH; Pellizzon, AC; Schultz, C; Testa, JR	1
Biel, MA; El-Naggar, AK; Machtay, M; Rosenthal, DI; Sinard, RJ; Weber, RS; Yom, SS	1
Chou, W; Lee, N; Puri, DR	1
Agrawal, A; Grecula, JC; Ozer, E; Rhoades, CA; Schuller, DE; Young, DC	2
Agrawal, A; Grecula, JC; Ozer, E; Rhoades, CA; Schuller, DE	1
Colpaert, C; Schrijvers, D; Van den Brande, J; Vermorken, JB	1
Aihara, T; Akisada, T; Fukuda, K; Gyoten, M; Harada, T; Hiratsuka, J; Imai, S; Imajo, Y; Kajihara, Y; Morita, N; Takemoto, T	1

Trials

8 trial(s) available for paclitaxel and Hypopharyngeal Cancer

Article	Year
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2009, Volume: 266, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Treatment Outcome	2009
Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. International journal of radiation oncology, biology, physics, 2012, Apr-01, Volume: 82, Issue:5 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Drug Administration Schedule; ErbB Receptors; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Papillomaviridae; Prospective Studies; Remission Induction; Squamous Cell Carcinoma of Head and Neck	2012
Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2011, Volume: 187, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Dose Fractionation, Radiation; Enteral Nutrition; Feasibility Studies; Female; Follow-Up Studies; Germany; Humans; Hypopharyngeal Neoplasms; Leukopenia; Male; Middle Aged; Mucositis; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy Dosage; Thrombocytopenia	2011
Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2003, Volume: 179, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Cohort Studies; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Metastasis; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Stomatitis; Survival Analysis; Time Factors	2003
Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck. Onkologie, 2003, Volume: 26, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome	2003
Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx. The Laryngoscope, 2006, Volume: 116, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Otorhinolaryngologic Surgical Procedures; Paclitaxel; Patient Compliance; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome	2006
Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma. Archives of otolaryngology--head & neck surgery, 2006, Volume: 132, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Feasibility Studies; Female; Humans; Hypopharyngeal Neoplasms; Laryngectomy; Male; Middle Aged; Ohio; Paclitaxel; Patient Compliance; Prospective Studies; Survival Rate; Treatment Outcome	2006
Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience. Archives of otolaryngology--head & neck surgery, 2007, Volume: 133, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mouth; Oropharyngeal Neoplasms; Paclitaxel; Patient Compliance; Prospective Studies; Survival Rate; Treatment Outcome	2007

Other Studies

18 other study(ies) available for paclitaxel and Hypopharyngeal Cancer

Article	Year
MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells. Molecular medicine reports, 2018, Volume: 18, Issue:2 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hypopharyngeal Neoplasms; Leupeptins; MAP Kinase Signaling System; Paclitaxel; T-Lymphocytes	2018
The Limitations of Collagen/CPP Hybrid Peptides as Carriers for Cancer Drugs to FaDu Cells. Molecules (Basel, Switzerland), 2019, Feb-14, Volume: 24, Issue:4 Topics: Cell Line, Tumor; Cell-Penetrating Peptides; Collagen; Drug Carriers; Drug Liberation; Endosomes; Gene Expression Regulation, Neoplastic; Heparan Sulfate Proteoglycans; Humans; Hypopharyngeal Neoplasms; Lysosomal Membrane Proteins; Paclitaxel; Surface Properties; Vesicular Transport Proteins	2019
Radiation-induced angiosarcoma of the parotid gland after postoperative radiotherapy for hypopharyngeal carcinoma. Auris, nasus, larynx, 2019, Volume: 46, Issue:6 Topics: Antineoplastic Agents; Brain Neoplasms; Diagnosis, Differential; Female; Hemangiosarcoma; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Parotid Neoplasms; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck	2019
Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Hypopharyngeal Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reproducibility of Results; RNA, Messenger; Signal Transduction; Time Factors	2013
MG132 reverse the malignant characteristics of hypopharyngeal cancer. Molecular medicine reports, 2014, Volume: 9, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hypopharyngeal Neoplasms; Inhibitory Concentration 50; Leupeptins; NF-kappa B; Paclitaxel; Proteasome Inhibitors; Protein Transport; Tumor Suppressor Protein p53	2014
[Metformin inhibits the proliferation of hypopharyngeal carcinoma Fadu cells and enhances the chemotherapeutic sensitivity of cells]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2014, Volume: 49, Issue:4 Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Drug Screening Assays, Antitumor; Humans; Hypopharyngeal Neoplasms; Metformin; Paclitaxel	2014
Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2009, Volume: 266, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome	2009
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2011, Volume: 187, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome	2011
FaDu cell characteristics induced by multidrug resistance. Oncology reports, 2011, Volume: 26, Issue:5 Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Multiple; Female; Humans; Hypopharyngeal Neoplasms; Male; Neoplasm Proteins; Paclitaxel; Tumor Cells, Cultured	2011
[A case of hypopharyngeal carcinoma in which a complete response to chemotherapy was achieved with docetaxel, cisplatin, 5-FU and levofolinate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Leucovorin; Male; Paclitaxel; Remission Induction; Taxoids	2002
Voice and swallowing in patients enrolled in a larynx preservation trial. Archives of otolaryngology--head & neck surgery, 2003, Volume: 129, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Deglutition; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Treatment Outcome; Voice; Voice Disorders	2003
[A case of posterior wall cancer of the hypopharynx treated with docetaxel followed by radiation]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:8 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Female; Humans; Hypopharyngeal Neoplasms; Paclitaxel; Taxoids	2003
Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2003, Volume: 68, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Hypopharyngeal Neoplasms; Imaging, Three-Dimensional; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Radiation Injuries; Tomography, X-Ray Computed	2003
Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas. Archives of otolaryngology--head & neck surgery, 2004, Volume: 130, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Audiometry, Pure-Tone; Auditory Threshold; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Hearing Loss, Sensorineural; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiotherapy; Radiotherapy Dosage	2004
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. American journal of clinical oncology, 2005, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Palliative Care; Radiation Dosage; Radiation Injuries; Remission Induction; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome	2005
Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results. American journal of clinical oncology, 2005, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Osteoradionecrosis; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Treatment Outcome	2005
Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Colitis; Cytomegalovirus Infections; Docetaxel; Fatal Outcome; Fluorouracil; Ganciclovir; Humans; Hypopharyngeal Neoplasms; Immune Tolerance; Male; Middle Aged; Paclitaxel; Taxoids	1999
[A case of advanced hypopharyngeal carcinoma successfully treated with superselective intra-arterial infusion of docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Infusions, Intra-Arterial; Male; Paclitaxel; Taxoids	2002